Deferasirox Tablet
Product Images NDC 69539-075

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69539-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Msn Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox 180mg 1000s Count

Deferasirox Tablets are film-coated and have a dosage that can be found in the package insert. Store them at a temperature between 20°C to 26°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F) to protect from moisture. The M.L No. is SMNTS/2014/FIG, and they are manufactured by MSN Laboratories Private Limited in Telangana, India. Distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ 08854-3714. They were issued in October 2019 and are Rx Only. Attention Pharmacists are instructed to dispense the Wedication Guide to each patient, and to keep drugs out of the reach of children.*

FDA Label Image

Deferasirox 180mg 30s Count

FDA Label Image

360mg-1000s (Deferasirox 360mg 1000s Count)

Deferasirox Tablets are a prescription medication with a dosage specified in the package insert. They should be stored at a temperature between 20°C to 25°C and protected from moisture. The product should be kept out of reach of children. The manufacturer is MSN Laboratories Private Limited located in Telangana, India, and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. The tablets are film-coated and each contains 360 mg of the medication. The product comes with a medication guide that should be dispensed to each patient by the pharmacist. The quantity of the tablets is 1000, and the NDC is 69539-075.99.*

FDA Label Image

360mg-30s (Deferasirox 360mg 30s Count)

Deferasirox Tablets are film-coated tablets with 60mg of dosage. It is important to store the tablets at a temperature between 20°C to 25°C and protect them from moisture. The medicine is manufactured by MSN Laboratories Private Limited in India and distributed by MSN Pharmaceuticals nc. &5 Qusno in Piscataway, NJ. The product information includes the MLNo., SIMNITS2014/FIG, and it is only available on prescription. A medication guide must be dispensed to each patient. The package contains 30 tablets.*

FDA Label Image

90mg-1000s (Deferasirox 90mg 1000s Count)

Dosage information for a medication is available in a package insert, with instructions to store the tablets at a specific temperature with permitted temperature excursions. The tablets are to be protected from moisture and kept out of the reach of children, and the prescription can be filled by a pharmacist who should provide a medication guide to each patient. The medication is manufactured in India and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. The text includes an issue date of October 2019 and a product code of DXOOXXK with 1000 tablets per package.*

FDA Label Image

90mg-30s (Deferasirox 90mg 30s Count)

Deferasirox Tablets are a prescription medication used to treat chronic iron overload caused by blood transfusions. The dosage information is not available in this text. The tablets should be stored at a temperature between 20°C to 25°C, protected from moisture and out of reach of children. The tablets are film-coated and come in a package of 30 tablets with 90 mg per tablet. Dispense the medication guide along with the tablets to each patient. The medication is manufactured by MSN Laboratories Private Limited in India and distributed by MSN Pharmaceuticals Inc. in New Jersey, USA. The product code is MLNo: SIMNTS2014F/G and the NDC number is 69-539-073-30.*

FDA Label Image

Figure (Deferasirox Figure)

FDA Label Image

Structure (Deferasirox Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.